Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study

Fig. 2

Box plot showing the distribution of BMI before bariatric surgery, at weight nadir, at the time of GLP1-RA initiation, and at 6 and 12 months of GLP1-RA therapy (n = 40, except at 6 months [n = 33]). GLP1-RA, glucagon-like peptide-1 receptor agonist; BMI, body mass index. * P-value < 0.0001 based on paired nonparametric tests (Wilcoxon signed-rank test)

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us